Impaired IFNγ transcription and translation drive tumor-specific CD8 T cell dysfunction 2252067

Abstract Introduction Tumor-specific CD8 T cells (TST) are often dysfunctional and fail to produce IFNγ, a cytokine essential for tumor elimination. How transcriptional and translational mechanisms contribute to this defect remains unclear. Methods We analyzed Ifng transcription and translation in adoptively transferred antigen-specific CD8 T cells in acute infection and liver tumors. Using an Ifng fluorescent reporter together with intracellular cytokine staining, we measured Ifng mRNA and protein at the single-cell level by flow cytometry. Results Early after antigen encounter, both TST and Listeria-primed effector T cells (Teff) expressed Ifng mRNA. In contrast to Teff, TST did not produce IFNγ protein, suggesting an early translational block. At later time points, Teff rapidly and robustly upregulated Ifng mRNA and IFNγ protein upon antigen restimulation. However, with continued tumor exposure, TST failed to upregulate Ifng mRNA in response to antigen, demonstrating a TST-specific Ifng transcriptional block. Consequently, IFNγ production in TST is impaired at both the transcriptional and translational level. Although the Ifng locus underwent similar chromatin remodeling in TST and Teff upon activation, chromatin accessibility diverged over time, suggesting epigenetic mechanisms may engender the Ifng transcriptional defect. Conclusion In future studies, we will epigenetically target the Ifng locus to restore IFNγ mRNA expression and further study and target the Ifng translational block to improve TST IFNγ production. Understanding these regulatory mechanisms in TST will potentially lead to new strategies to strengthen antitumor T cell immunity. Funding Source n/a Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.132
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impaired IFNγ transcription and translation drive tumor-specific CD8 T cell dysfunction 2252067

Mary Philip, Zachary Ewell
The Journal of Immunology
Immunotherapy and Immune Responses
article

Impaired IFNγ transcription and translation drive tumor-specific CD8 T cell dysfunction 2252067

Mary Philip, Zachary Ewell
article en

Abstract

Abstract Introduction Tumor-specific CD8 T cells (TST) are often dysfunctional and fail to produce IFNγ, a cytokine essential for tumor elimination. How transcriptional and translational mechanisms contribute to this defect remains unclear. Methods We analyzed Ifng transcription and translation in adoptively transferred antigen-specific CD8 T cells in acute infection and liver tumors. Using an Ifng fluorescent reporter together with intracellular cytokine staining, we measured Ifng mRNA and protein at the single-cell level by flow cytometry. Results Early after antigen encounter, both TST and Listeria-primed effector T cells (Teff) expressed Ifng mRNA. In contrast to Teff, TST did not produce IFNγ protein, suggesting an early translational block. At later time points, Teff rapidly and robustly upregulated Ifng mRNA and IFNγ protein upon antigen restimulation. However, with continued tumor exposure, TST failed to upregulate Ifng mRNA in response to antigen, demonstrating a TST-specific Ifng transcriptional block. Consequently, IFNγ production in TST is impaired at both the transcriptional and translational level. Although the Ifng locus underwent similar chromatin remodeling in TST and Teff upon activation, chromatin accessibility diverged over time, suggesting epigenetic mechanisms may engender the Ifng transcriptional defect. Conclusion In future studies, we will epigenetically target the Ifng locus to restore IFNγ mRNA expression and further study and target the Ifng translational block to improve TST IFNγ production. Understanding these regulatory mechanisms in TST will potentially lead to new strategies to strengthen antitumor T cell immunity. Funding Source n/a Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)

The Journal of ImmunologyVol. 215(Supplement_1)
Vanderbilt University (US), Vanderbilt University Medical Center (US)
Openalex Percentile: Top 14%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.